Reference

1. Müller, Rainer H., KarstenMäder, and Sven Gohla. "Solid lipid nanoparticles (SLN) for controlled drug delivery–a review of the state of the art." European journal of pharmaceutics and biopharmaceutics 50.1 (2000): 161-177.
2. Fang, Chia-Lang, Saleh A Al-Suwayeh, and Jia-You Fang. "Nanostructured lipid carriers (NLCs) for drug delivery and targeting." Recent patents on nanotechnology 7.1 (2013): 41-55
3. Khan, Saba, et al. "Nanostructured lipid carriers: an emerging platform for improving oral bioavailability of lipophilic drugs." International journal of pharmaceutical investigation 5.4 (2015): 182.
4. J. Pardeike, A. Hommoss, R.H. Muller, Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products, Int. J. Pharm. 366 (2009) 170–184, https:// doi.org/10.1016/j.ijpharm.2008.10.003.
5. Beloqui, Ana, et al. "Nanostructured lipid carriers: Promising drug delivery systems for future clinics." Nanomedicine: Nanotechnology, biology and medicine 12.1 (2016): 143-161.
6. Selvamuthukumar, Subramanian, and RamaiyanVelmurugan. "Nanostructured lipid carriers: a potential drug carrier for cancer chemotherapy." Lipids in health and disease 11.1 (2012): 1-8.
7. Carbone, Claudia, et al. "Pharmaceutical and biomedical applications of lipid-based nanocarriers." Pharmaceutical patent analyst 3.2 (2014): 199-215.
8. Müller, R. H., M. Radtke, and SA12176234 Wissing. "Nanostructured lipid matrices for improved microencapsulation of drugs." International journal of pharmaceutics 242.1-2 (2002): 121-128.
9. Shidhaye, S. S., et al. "Solid lipid nanoparticles and nanostructured lipid carriers-innovative generations of solid lipid carriers." Current drug delivery 5.4 (2008): 324-331.
10. Das, Surajit, WaiKiong Ng, and Reginald BH Tan. "Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?." European journal of pharmaceutical sciences 47.1 (2012): 139-151.
11. Balguri, SaiPrachetan, Goutham R. Adelli, and SoumyajitMajumdar. "Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues." European Journal of Pharmaceutics and Biopharmaceutics 109 (2016): 224-235.
12. Wu, Miaojing, et al. "Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery." Drug delivery 23.8 (2016): 2720-2725.
13. Das, Surajit, and AnumitaChaudhury. "Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery." AapsPharmscitech 12 (2011): 62-76.
14. Lim, Wei Meng, et al. "Formulation and delivery of itraconazole to the brain using a nanolipid carrier system." International journal of nanomedicine (2014): 2117-2126.
15. Kutscher, Marika, et al. "Influence of salt type and ionic strength on self-assembly of dextran sulfate-ciprofloxacin nanoplexes." International journal of pharmaceutics 486.1-2 (2015): 21-29.
16. El-Helw, Abdel-Rahim M., and Usama A. Fahmy. "Improvement of fluvastatin bioavailability by loading on nanostructured lipid carriers." International journal of nanomedicine (2015): 5797-5804.
17. Shah, Nirmal V., et al. "Nanostructured lipid carriers for oral bioavailability enhancement of raloxifene: Design and in vivo study." Journal of advanced research 7.3 (2016): 423-434.
18. Iqbal, MdAsif, et al. "Nanostructured lipid carriers system: recent advances in drug delivery." Journal of drug targeting 20.10 (2012): 813-830.
19. Zhang, Kunchi, et al. "Preparation, characterization, and in vivo pharmacokinetics of nanostructured lipid carriers loaded with oleanolic acid and gentiopicrin." International journal of nanomedicine (2013): 3227-3239.
20. Joshi, M., and V. Patravale. "Formulation and evaluation of nanostructured lipid carrier (NLC)–based gel of Valdecoxib." Drug development and industrial pharmacy 32.8 (2006): 911-918.
21. A.M. Bhagurkar, M.A. Repka, S.N. Murthy, A novel approach for the development V.R. Salvi and P. Pawar Journal of Drug Delivery Science and Technology 51 (2019) 255–267 264 of a Nanostructured Lipid Carrier formulation by hot-melt extrusion technology, J. Pharm. Sci. 106 (2017) 1085–1091, https://doi.org/10.1016/j.xphs.2016.12. 015
22. Carbone, Claudia, et al. "Lipid-based nanocarriers for drug delivery and targeting: a patent survey of methods of production and characterization." Pharmaceutical patent analyst 2.5 (2013): 665-677.
23. Beloqui, Ana, et al. "Fate of nanostructured lipid carriers (NLCs) following the oral route: design, pharmacokinetics and biodistribution." Journal of microencapsulation 31.1 (2014): 1-8.
24. Shangguan, Mingzhu, et al. "Binary lipids-based nanostructured lipid carriers for improved oral bioavailability of silymarin." Journal of biomaterials applications 28.6 (2014): 887-896.
25.  Tian, Cihui, et al. "N-acetyl-L-cysteine functionalized nanostructured lipid carrier for improving oral bioavailability of curcumin: preparation, in vitro and in vivo evaluations." Drug delivery 24.1 (2017): 1605-1616.
26. Ling Tan, Janet Sui, Clive J. Roberts, and NashiruBilla. "Mucoadhesive chitosan-coated nanostructured lipid carriers for oral delivery of amphotericin B." Pharmaceutical development and technology 24.4 (2019): 504-512.
27. Khan, Saba, et al. "Tacrolimus-loaded nanostructured lipid carriers for oral delivery-in vivobioavailability enhancement." European Journal of Pharmaceutics and Biopharmaceutics 109 (2016): 149-157.
28. Zhuang, Chun-Yang, et al. "Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability." International journal of pharmaceutics 394.1-2 (2010): 179-185.
29. Lin, Congcong, et al. "A novel oral delivery system consisting in “drug-in cyclodextrin-in nanostructured lipid carriers” for poorly water-soluble drug: Vinpocetine." International Journal of Pharmaceutics 465.1-2 (2014): 90-96.
30. Rizwanullah, Md, Saima Amin, and Javed Ahmad. "Improved pharmacokinetics and antihyperlipidemic efficacy of rosuvastatin-loaded nanostructured lipid carriers." Journal of drug targeting 25.1 (2017): 58-74.
31. Elmowafy, Mohammed, et al. "Atorvastatin-loaded nanostructured lipid carriers (NLCs): strategy to overcome oral delivery drawbacks." Drug delivery 24.1 (2017): 932-941.
32. Fang, Guihua, et al. "Cysteine-functionalized nanostructured lipid carriers for oral delivery of docetaxel: a permeability and pharmacokinetic study." Molecular pharmaceutics 12.7 (2015): 2384-2395.
33. Dudhipala, Narendar, KarthikYadavJanga, and ThirupathiGorre. "Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation." Artificial cells, nanomedicine, and biotechnology 46.sup2 (2018): 616-625.
34. Elmowafy, Mohammed, et al. "Multifunctional carbamazepine loaded nanostructured lipid carrier (NLC) formulation." International journal of pharmaceutics 550.1-2 (2018): 359-371.
35. Czajkowska-Ko?nik, Anna, Marta Szekalska, and KatarzynaWinnicka. "Nanostructured lipid carriers: A potential use for skin drug delivery systems." Pharmacological Reports 71.1 (2019): 156-166.
36. Puglia, Carmelo, and Francesco Bonina. "Lipid nanoparticles as novel delivery systems for cosmetics and dermal pharmaceuticals." Expert Opinion on Drug Delivery 9.4 (2012): 429-441.
37. Gaba, Bharti, et al. "Nanostructured lipid carrier system for topical delivery of terbinafine hydrochloride." Bulletin of Faculty of Pharmacy, Cairo University 53.2 (2015): 147-159.
38. Lin, Wen Jen, and Yi Shein Duh. "Nanostructured lipid carriers for transdermal delivery of acid labile lansoprazole." European Journal of Pharmaceutics and Biopharmaceutics 108 (2016): 297-303.
39. Kawadkar, Jitendra, et al. "Formulation, characterization and in vitro–in vivo evaluation of flurbiprofen-loaded nanostructured lipid carriers for transdermal delivery." Drug development and industrial pharmacy 39.4 (2013): 569-578.
40. Kutscher, Marika, et al. "Influence of salt type and ionic strength on self-assembly of dextran sulfate-ciprofloxacin nanoplexes." International journal of pharmaceutics 486.1-2 (2015): 21-29.
41. Nagaich, Upendra, and NehaGulati. "Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization." Drug delivery and translational research 6 (2016): 289-298.
42. Tripathi, Priyanka, et al. "Carbomer gel bearing methotrexate loaded lipid nanocontainers shows improved topical delivery intended for effective management of psoriasis." International journal of biological macromolecules 120 (2018): 1322-1334.
43. Guo, Teng, et al. "Nanostructured lipid carriers for percutaneous administration of alkaloids isolated from Aconitum sinomontanum." Journal of nanobiotechnology 13 (2015): 1-14.
44. Shamma, Rehab Nabil, and Mona Hassan Aburahma. "Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia." International journal of nanomedicine (2014): 5449-5460.
45. You, Peijun, Ran Yuan, and Chuanyu Chen. "Design and evaluation of lidocaine-and prilocaine-coloadednanoparticulate drug delivery systems for topical anesthetic analgesic therapy: a comparison between solid lipid nanoparticles and nanostructured lipid carriers." Drug Design, Development and Therapy (2017): 2743-2752.
46. Keck, C. M., et al. "A new concept for the treatment of atopic dermatitis: Silver–nanolipid complex (sNLC)." International journal of pharmaceutics 462.1-2 (2014): 44-51.
47. Brugè, Francesca, et al. "A comparative study on the possible cytotoxic effects of different nanostructured lipid carrier (NLC) compositions in human dermal fibroblasts." International Journal of Pharmaceutics 495.2 (2015): 879-885.
48. Sánchez-López, E., et al. "Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye–Part I–Barriers and determining factors in ocular delivery." European Journal of Pharmaceutics and Biopharmaceutics 110 (2017): 70-75.
49. Fu, Tian, et al. "Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy." Journal of liposome research 27.3 (2017): 228-233.